Substantial insider selling of Alnylam Pharmaceuticals share...
Substantial insider selling of Alnylam Pharmaceuticals shares over the last quarter, with no recorded purchases, may suggest insiders think shares are not cheap. Insider ownership suggests alignment with shareholder interests, but history of sales warrants caution before buying.
Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment